DE69631597D1 - Kombination aus einem beta rezeptorblocker und einem opioid - Google Patents

Kombination aus einem beta rezeptorblocker und einem opioid

Info

Publication number
DE69631597D1
DE69631597D1 DE69631597T DE69631597T DE69631597D1 DE 69631597 D1 DE69631597 D1 DE 69631597D1 DE 69631597 T DE69631597 T DE 69631597T DE 69631597 T DE69631597 T DE 69631597T DE 69631597 D1 DE69631597 D1 DE 69631597D1
Authority
DE
Germany
Prior art keywords
pct
combination
opioid
pharmaceutically acceptable
receptor blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69631597T
Other languages
English (en)
Other versions
DE69631597T2 (de
Inventor
Arne Eek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69631597D1 publication Critical patent/DE69631597D1/de
Publication of DE69631597T2 publication Critical patent/DE69631597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
DE69631597T 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid Expired - Fee Related DE69631597T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9503476 1995-10-06
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination
PCT/SE1996/001248 WO1997012634A1 (en) 1995-10-06 1996-10-03 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID

Publications (2)

Publication Number Publication Date
DE69631597D1 true DE69631597D1 (de) 2004-03-25
DE69631597T2 DE69631597T2 (de) 2004-12-16

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631597T Expired - Fee Related DE69631597T2 (de) 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid

Country Status (14)

Country Link
US (1) US5908847A (de)
EP (1) EP0862462B1 (de)
JP (1) JP4135977B2 (de)
AT (1) ATE259657T1 (de)
AU (1) AU706794B2 (de)
CA (1) CA2233677C (de)
DE (1) DE69631597T2 (de)
DK (1) DK0862462T3 (de)
ES (1) ES2214548T3 (de)
NO (1) NO318387B1 (de)
NZ (1) NZ319746A (de)
PT (1) PT862462E (de)
SE (1) SE9503476D0 (de)
WO (1) WO1997012634A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
JP2013523764A (ja) * 2010-03-30 2013-06-17 アルジーノミクス インコーポレイテッド 体性感覚障害治療用の組成物と方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
NO981222L (no) 1998-03-18
NZ319746A (en) 1999-11-29
JPH11513386A (ja) 1999-11-16
PT862462E (pt) 2004-06-30
NO981222D0 (no) 1998-03-18
US5908847A (en) 1999-06-01
AU7233596A (en) 1997-04-28
ES2214548T3 (es) 2004-09-16
JP4135977B2 (ja) 2008-08-20
CA2233677C (en) 2006-08-29
DK0862462T3 (da) 2004-05-10
AU706794B2 (en) 1999-06-24
ATE259657T1 (de) 2004-03-15
CA2233677A1 (en) 1997-04-10
EP0862462A1 (de) 1998-09-09
DE69631597T2 (de) 2004-12-16
NO318387B1 (no) 2005-03-14
WO1997012634A1 (en) 1997-04-10
SE9503476D0 (sv) 1995-10-06
EP0862462B1 (de) 2004-02-18

Similar Documents

Publication Publication Date Title
IL154583A0 (en) Active agent delivery systems and methods for protecting and administering active agents
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
BG105534A (en) 5ht1 means and method for the treatment of migraine
IL112520A0 (en) Treatment of normal tension glaucoma
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
DE69631597D1 (de) Kombination aus einem beta rezeptorblocker und einem opioid
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
PL312198A1 (en) Application of procaine in obtaining a pharmaceutical preparation of analgesic activity with minimum motorial blocking effect
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
WO1998031335A3 (fr) Utilisation d'un antagoniste et/ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
EP1584333A3 (de) Verwendung von Acetylcoenzyme A Inhibitoren zur Behandlung von Alzheimer
BG100479U (en) Medicament for the local treatment of otitis
BR0005039A (pt) Antagonistas do receptor nk-1 e eletriptano para o tratamento da enxaqueca

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee